Skip to main content
. 2013 May 30;13:251. doi: 10.1186/1471-2334-13-251

Table 1.

MIC50 and MIC90 values and percent antimicrobial resistance for A. baumannii and P. aeruginosa clinical isolates

Antimicrobial agent  
A. baumannii (n = 101)
P. aeruginosa (n = 15)
Breakpoint forresistancea (mg/L) %Resistance Range(mg/L) MIC50(mg/L) MIC90(mg/L) Breakpoint forresistancea (mg/L) %Resistance Range(mg/L) MIC50(mg/L) MIC90(mg/L)
Amikacin
≥64
85
<2- > 1024
>1024
>1024
≥64
60
<2- > 1024
64
>1024
Arbekacin
-
-
<2- > 1024
>1024
>1024
-
-
2- > 1024
2
>1024
Aztreonam
-
-
<2- > 256
128
>256
≥32
46
4- > 256
16
>256
Ceftazidime
≥32
55
<4- > 512
>512
>512
≥32
46
<4- > 512
16
>512
Ciprofloxacin
≥4
98
<1- > 128
128
>128
≥4
66
<1-64
8
32
Colistin
≥4
6
<0.25-4
2
2
≥8
0
<0.25-0.5
<0.25
0.5
Gentamicin
≥16
91
<2- > 1024
>1024
>1024
≥16
66
<2- > 1024
256
>1024
Imipenem
≥16
48
<4-128
16
32
≥8
53
<4-64
16
32
Meropenem
≥16
51
<4- > 256
32
64
≥8
53
<4-32
16
32
Piperacillin
≥128
100
<4- > 512
>512
>512
≥128
46
<4- > 512
32
256
Piperacillin/Tazobactam ≥128/4 52 <4- > 512 256 512 ≥128/4 13 <4-512 32 128

aBreakpoints for antimicrobial resistance were determined according to the guidelines of the Clinical and Laboratory Standards Institute (M07-A9).

HHS Vulnerability Disclosure